The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Estimated Life Expectancy in a Scottish Cohort With Type 1 Diabetes, 2008-2010
Open accessAbstract
IMPORTANCE: Type 1 diabetes has historically been associated with a significant reduction in life expectancy. Major advances in treatment of type 1 diabetes have occurred in the past 3 decades. Contemporary estimates of the effect of type 1 diabetes on life expectancy are needed. OBJECTIVE: To examine current life expectancy in people with and without type 1 diabetes in Scotland. We also examined whether any loss of life expectancy in patients with type 1 diabetes is confined to those who develop kidney disease. DESIGN, SETTING, AND PARTICIPANTS: Prospective cohort of all individuals alive in Scotland with type 1 diabetes who were aged 20 years or older from 2008 through 2010 and were in a nationwide register (n=24,691 contributing 67,712 person-years and 1043 deaths). MAIN OUTCOMES AND MEASURES: Differences in life expectancy between those with and those without type 1 diabetes and the percentage of the difference due to various causes. RESULTS: Life expectancy at an attained age of 20 years was an additional 46.2 years among men with type 1 diabetes and 57.3 years among men without it, an estimated loss in life expectancy with diabetes of 11.1 years (95% CI, 10.1-12.1). Life expectancy from age 20 years was an additional 48.1 years among women with type 1 diabetes and 61.0 years among women without it, an estimated loss with diabetes of 12.9 years (95% CI, 11.7-14.1). Even among those with type 1 diabetes with an estimated glomerular filtration rate of 90 mL/min/1.73 m2 or higher, life expectancy was reduced (49.0 years in men, 53.1 years in women) giving an estimated loss from age 20 years of 8.3 years (95% CI, 6.5-10.1) for men and 7.9 years (95% CI, 5.5-10.3) for women. Overall, the largest percentage of the estimated loss in life expectancy was related to ischemic heart disease (36% in men, 31% in women) but death from diabetic coma or ketoacidosis was associated with the largest percentage of the estimated loss occurring before age 50 years (29.4% in men, 21.7% in women). CONCLUSIONS AND RELEVANCE: Estimated life expectancy for patients with type 1 diabetes in Scotland based on data from 2008 through 2010 indicated an estimated loss of life expectancy at age 20 years of approximately 11 years for men and 13 years for women compared with the general population without type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cardiovascular disease remains the major cause of premature morbidity and mortality, with data119,120 suggesting an 8–13-year shorter life expectancy for people with type 1 diabetes than for healthy individuals.”
From Type 1 diabetes (2018) · cites this paper as [120]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Due in part to the success of modern diabetes management, people with type 1 diabetes are living longer, and the population of these people over 65 years of age is growing (121-123).”
From 13. Older Adults: Standards of Care in Diabetes—2024 (2024) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Due in part to the success of modern diabetes management, people with type 1 diabetes are living longer, and the population of these people over 65 years of age is growing (136-138).”
From 13. Older Adults: Standards of Care in Diabetes—2025 (2025) · cites this paper as [136]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In Scotland, mortality rates in 2008–2010 increased from 31.9 and 24.2 per 1,000 person-years in men and women, respectively, with T1DM who were aged 60–64 years to 142.7 in men and 171.3 in women aged ≥80 years39.”
From The epidemiology of type 1 diabetes mellitus in older adults (2025) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In Scotland, reductions in life expectancy for people with T1DM aged 60–64 years were 5.6 years and 7.1 years for men and women, respectively39.”
From The epidemiology of type 1 diabetes mellitus in older adults (2025) · cites this paper as [39]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Due in part to the success of modern diabetes management, people with type 1 diabetes are living longer, and the population of people over 65 years with type 1 diabetes is growing (154–156).”
From 13. Older Adults: Standards of Care in Diabetes—2026 (2026) · cites this paper as [154]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2000) · doi:10.32614/r.manuals · Cited by 355,893
Patterson, C. C., Dahlquist, G. G., Gyürüs, E., Green, A., & Soltész, G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60568-7 · Cited by 1,854
Introduction to Stochastic Processes in Biostatistics
Bartlett, M. S., & Chiang, C. L. (1969) · Revue de l Institut International de Statistique / Review of the International Statistical Institute · doi:10.2307/1402301 · Cited by 684
The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes
Groop, P.-H., Thomas, M. C., Moran, J. L., Wadèn, J., Thorn, L. M., Mäkinen, V.-P., Rosengård-Bärlund, M., Saraheimo, M., Hietala, K., Heikkilä, O., et al. (2009) · Diabetes · doi:10.2337/db08-1543 · Cited by 638
Measuring and explaining the change in life expectancies
Arriaga, E. E. (1984) · Demography · doi:10.2307/2061029 · Cited by 630
Type 1 Diabetes Mellitus and Cardiovascular Disease
de Ferranti, S. D., de Boer, I. H., Fonseca, V. A., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000034 · Cited by 516
de Ferranti, S. D., de Boer, I. H., Fonseca, V. A., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Diabetes Care · doi:10.2337/dc14-1720 · Cited by 444
High Risk of Cardiovascular Disease in Patients With Type 1 Diabetes in the U.K.
Soedamah‐Muthu, S. S., Fuller, J., Mulnier, H. E., Raleigh, V. S., Lawrenson, R. A., & Colhoun, H. M. (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-1433 · Cited by 395
Self-citationLivingstone, S. J., Looker, H. C., Hothersall, E. J., Wild, S. H., Lindsay, R. S., Chalmers, J., Cleland, S. J., Leese, G., McKnight, J. A., Morris, A. D., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001321 · Cited by 356
Self-citationOrchard, T. J., Secrest, A. M., Miller, R. G., & Costacou, T. (2010) · Diabetologia · doi:10.1007/s00125-010-1860-3 · Cited by 317
Cited by
Sorted by citations
Items 201–300 of 622
Raman, S., Dai, H. D., DeLurgio, S. A., Williams, D. D., Lind, M., Patton, S. R., Spertus, J. A., Kosiborod, M., & Clements, M. A. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12300 · Cited by 25
Cardiovascular complications of type 1 diabetes: update on the renal link
Orchard, T. J., & Costacou, T. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0949-7 · Cited by 26
C-Peptide replacement therapy in type 1 diabetes: are we in the trough of disillusionment?
Pinger, C. W., Entwistle, K. E., Bell, T. M., Liu, Y., & Spence, D. M. (2017) · Molecular BioSystems · doi:10.1039/c7mb00199a · Cited by 25
Development of a life expectancy table for individuals with type 1 diabetes
Tran‐Duy, A., Knight, J., Clarke, P., Svensson, A., Eliasson, B., & Palmer, A. J. (2021) · Diabetologia · doi:10.1007/s00125-021-05503-6 · Cited by 24
PD-1 pathway-mediated regulation of islet-specific CD4+ T cell subsets in autoimmune diabetes
Martinov, T., Spanier, J. A., Pauken, K. E., & Fife, B. T. (2016) · Immunoendocrinology · doi:10.14800/ie.1164 · Cited by 24
Are low sun exposure and/or vitamin D risk factors for type 1 diabetes?
Miller, K. M., Hart, P. H., de Klerk, N. H., Davis, E. A., & Lucas, R. M. (2016) · Photochemical & Photobiological Sciences · doi:10.1039/c6pp00294c · Cited by 26
Chan, J. K. N., Wong, C. S. M., Or, P. C. F., Chen, E. Y. H., & Chang, W. C. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.08.263 · Cited by 23
Immunotherapy for type 1 diabetes
Allen, L. A., & Dayan, C. M. (2021) · British Medical Bulletin · doi:10.1093/bmb/ldab027 · Cited by 24
Serné, E. H., Roze, S., Buompensiere, M. I., Valentine, W. J., de Portu, S., & de Valk, H. W. (2022) · Advances in Therapy · doi:10.1007/s12325-022-02058-9 · Cited by 24
Toffanin, C., Magni, L., & Cobelli, C. (2021) · IEEE Transactions on Medical Robotics and Bionics · doi:10.1109/tmrb.2021.3075775 · Cited by 22
Chiesa, S. T., Marcovecchio, M. L., Benitez‐Aguirre, P., Cameron, F. J., Craig, M. E., Couper, J., Davis, E. A., Dalton, R. N., Daneman, D., Donaghue, K. C., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15721 · Cited by 22
The Risk Threshold for Hemoglobin A1c Associated With Albuminuria: A Population-Based Study in China
Lian, H., Wu, H., Ning, J., Lin, D., Huang, C., Li, F., Liang, Y. J., Qi, Y., Ren, M., Yan, L., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.673976 · Cited by 22
Toschi, E. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.10.006 · Cited by 23
van Mark, G., Lanzinger, S., Barion, R., Degenhardt, M., Badis, S., Noll, H., Danne, T., Bramlage, P., Seufert, J., & Holl, R. W. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819830867 · Cited by 22
Lentine, K. L., Alhamad, T., Cheungpasitporn, W., Tan, J. C., Chang, S., COOPER, M. M., Dadhania, D. M., Axelrod, D. A., Schnitzler, M. A., Ouseph, R., et al. (2020) · Transplantation Direct · doi:10.1097/txd.0000000000001043 · Cited by 22
Toward Disease-Modifying Therapies in Type 1 Diabetes: Focus on Teplizumab
Mathieu, C., Sims, E. K., Chatenoud, L., James, E. A., Atkinson, M. A., & Herold, K. C. (2025) · Diabetes Care · doi:10.2337/dci25-0066 · Cited by 23
Shinohara, M., Tashiro, Y., Shinohara, M., Hirokawa, J., Suzuki, K., Onishi‐Takeya, M., Mukouzono, M., Takeda, S., Saito, T., Fukumori, A., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901028rr · Cited by 21
Coulson, D. J., Bakhashab, S., Latief, J. S., & Weaver, J. U. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02785-7 · Cited by 21
Tamara, A., Coulson, D. J., Latief, J. S., Bakhashab, S., & Weaver, J. U. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02332-7 · Cited by 21
Dei, A., Aldigeri, R., Mantovani, A., Masulli, M., Palmisano, L., Cavalot, F. L., Bonomo, K., Baroni, M. G., Cossu, E., Cavallo, M. G., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad127 · Cited by 23
Evans‐Cheung, T. C., Bodansky, H. J., Parslow, R. C., & Feltbower, R. G. (2017) · Diabetic Medicine · doi:10.1111/dme.13544 · Cited by 21
Yang, D., Zhou, J., Garstka, M. A., Xu, Q., Li, Q., Wang, L., Ren, L., Ji, Q., & Liu, T. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02736-2 · Cited by 23
Plana‐Ripoll, O., Dreier, J. W., Momen, N. C., Prior, A., Weye, N., Mortensen, P. B., Pedersen, C. B., Iburg, K. M., Christensen, M. K., Laursen, T. M., et al. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1004023 · Cited by 20
Zala, A., & Thomas, R. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac115 · Cited by 20
Doubova, S. V., Ferreira‐Hermosillo, A., Pérez‐Cuevas, R., Barsoe, C., Gryzbowski-Gainza, E., & Valencia, J. E. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3412-3 · Cited by 21
Briganti, E. M., Summers, J. C., Fitzgerald, Z. A., Lambers, L. N. J., & Cohen, N. D. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0215 · Cited by 20
Kuo, R. Y. L., Ng, M., Prieto‐Alhambra, D., & Furniss, D. (2019) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000006551 · Cited by 20
Importance of Identifying Novel Biomarkers of Microvascular Damage in Type 1 Diabetes
Marcovecchio, M. L. (2020) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-020-00483-6 · Cited by 20
Mortality in Type 1 Diabetes in the Current Era
Katz, M. L., & Laffel, L. M. (2015) · JAMA · doi:10.1001/jama.2014.16327 · Cited by 21
Cohort Profile: Scottish Diabetes Research Network Type 1 Bioresource Study (SDRNT1BIO)
Akbar, T., McGurnaghan, S. J., Palmer, C. N. A., Livingstone, S. J., Petrie, J. R., Chalmers, J., Lindsay, R. S., McKnight, J. A., Pearson, D. W. M., Patrick, A. W., et al. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw152 · Cited by 20
Self-citationVoorhees, H. L., & Smith, M. H. (2019) · Qualitative Health Research · doi:10.1177/1049732319868985 · Cited by 19
Duration of diabetes-related complications and mortality in type 1 diabetes: a national cohort study
Bjerg, L., Guðbjörnsdóttir, S., Franzén, S., Carstensen, B., Witte, D. R., Jørgensen, M. E., & Svensson, A. (2021) · International Journal of Epidemiology · doi:10.1093/ije/dyaa290 · Cited by 19
Allo Beta Cell transplantation: specific features, unanswered questions, and immunological challenge
Caldara, R., Tomajer, V., Monti, P., Sordi, V., Citro, A., Chimienti, R., Gremizzi, C., Catarinella, D., Tentori, S., Paloschi, V., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1323439 · Cited by 19
Ahlén, E., Pivodic, A., Wedel, H., Dahlqvist, S., Kosiborod, M., & Lind, M. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816652901 · Cited by 19
Insulins NPH, glargine, and detemir, and risk of severe hypoglycemia among working-age adults*
Strandberg, A. Y., Khanfir, H., Mäkimattila, S., Saukkonen, T. T., Strandberg, T. E., & Hoti, F. J. (2016) · Annals of Medicine · doi:10.1080/07853890.2016.1278302 · Cited by 19
Challenges in pancreas transplantation
Sharples, E. J., Mittal, S., & Friend, P. J. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0865-x · Cited by 19
The clinical potential of low-level C-peptide secretion
Ludvigsson, J. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2016.1210513 · Cited by 19
Voss, T. S., Vendelbo, M. H., Kampmann, U., Pedersen, S. B., Nielsen, T. S., Johannsen, M., Svart, M. V., Jessen, N., & Møller, N. (2019) · Diabetologia · doi:10.1007/s00125-018-4785-x · Cited by 18
Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs Under Development
Mittermayer, F., Caveney, E. J., OLIVEIRA, C. D. F., Fleming, G. A., Gourgiotis, L., Puri, M., Tai, L.-J., & Turner, J. R. (2016) · Current Diabetes Reviews · doi:10.2174/1573399812666160413115655 · Cited by 19
LPS enhances CTB-INSULIN induction of IDO1 and IL-10 synthesis in human dendritic cells
Kim, N.-S., Torrez, T. W., & Langridge, W. H. R. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2019.03.003 · Cited by 18
Zhang, F., Guo, R., Cui, W., Wang, L., Xiao, J., Shang, J., & Zhao, Z. (2021) · Renal Failure · doi:10.1080/0886022x.2021.1937219 · Cited by 18
Allcock, B., Stewart, R., & Jackson, M. C. (2021) · Diabetic Medicine · doi:10.1111/dme.14663 · Cited by 18
The Cost of Control: Cost-effectiveness Analysis of Hybrid Closed-Loop Therapy in Youth
Pease, A., Callander, E. J., Zomer, E., Abraham, M. B., Davis, E. A., Jones, T. W., Liew, D., & Zoungas, S. (2022) · Diabetes Care · doi:10.2337/dc21-2019 · Cited by 19
Buchmann, M., Tuncer, O., Auzanneau, M., Eckert, A. J., Rosenbauer, J., Reitzle, L., Heidemann, C., Holl, R. W., & Thamm, R. (2023) · PubMed Central · doi:10.25646/11439 · Cited by 18
Viñals, C., Conget, I., Granados, M., Giménez, M., & Amor, A. J. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01616-4 · Cited by 19
Poulsen, C., Jesse, K., Carstensen, B., Frimodt‐Møller, M., Hansen, T. W., Persson, F., Vistisen, D., & Rossing, P. R. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.09.010 · Cited by 20
Pulsed electromagnetic fields alleviate streptozotocin‑induced diabetic muscle atrophy
Yang, J., Sun, L., Fan, X., Yin, B., Kang, Y., An, S.-C., & Tang, L. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9067 · Cited by 18
O’Reilly, J. E., Blackbourn, L. A. K., Caparrotta, T. M., Jeyam, A., Kennon, B., Leese, G., Lindsay, R. S., McCrimmon, R. J., McGurnaghan, S. J., McKeigue, P., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05173-w · Cited by 18
Self-citationFelix dies natalis, insulin… ceterum autem censeo “beta is better”
Piemonti, L. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01737-3 · Cited by 18
Arterial Stiffness in Type 1 Diabetes: The Case for the Arterial Wall Itself as a Target Organ
González-Clemente, J. M., Cano, A., Albert, L., Giménez‐Palop, O., Romero, A., Berlanga, E., Vendrell, J. J., & Llauradó, G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163616 · Cited by 20
Voeltz, D., Brinks, R., Tönnies, T., & Hoyer, A. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-003156 · Cited by 17
Svart, M. V., Kampmann, U., Voss, T. S., Pedersen, S. B., Johannsen, M., Rittig, N. F., Poulsen, P. L., Nielsen, T. S., Jessen, N., & Møller, N. (2016) · Diabetes · doi:10.2337/db15-1645 · Cited by 17
Hero, C., Karlsson, S. A., Franzén, S., Svensson, A., Miftaraj, M., Guðbjörnsdóttir, S., Sundell, K. A., Eliasson, B., & Eeg‐Olofsson, K. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000719 · Cited by 17
Ambinathan, J. P. N., Sridhar, V. S., Lytvyn, Y., Lovblom, L. E., Liu, H., Bjornstad, P., Perkins, B. A., Lovshin, J. A., & Cherney, D. Z. I. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.107880 · Cited by 19
Lifetime risk and years lost to type 1 and type 2 diabetes in Denmark, 1996–2016
Carstensen, B., Rønn, P. F., & Jørgensen, M. E. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001065 · Cited by 17
Dunger, D. B. (2016) · Diabetic Medicine · doi:10.1111/dme.13299 · Cited by 18
The influence of food order on postprandial glucose levels in children with type 1 diabetes
Faber, E. M., van Kampen, P. M., Boers, A. C.-D., Houdijk, E. C. A. M., & van der Kaay, D. C. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12640 · Cited by 17
Amor, A. J., Ortega, E., Giménez, M., Cofán, M., Blanco, J., Pané, A., Boswell, L., Vinagre, I., Esmatjes, E., & Conget, I. (2019) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2019.02.004 · Cited by 17
Oral Health Status of Children Living with Type 1 Diabetes Mellitus
Bányai, D., Végh, D., Vegh, A., Ujpál, M., Payer, M., Biczó, Z., Triebl, Z., Mukaddam, K., Herber, V., Jakse, N., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19010545 · Cited by 16
Roser, P., Kalscheuer, H., Groener, J. B., Lehnhoff, D., Klein, R., Auffarth, G. U., Nawroth, P. P., Schuett, F., & Rudofsky, G. (2016) · Journal of Diabetes Research · doi:10.1155/2016/4101890 · Cited by 16
Gaps in life expectancy for people with type 1 diabetes
Stene, L. C. (2016) · Diabetologia · doi:10.1007/s00125-016-3943-2 · Cited by 16
Strategically Playing with Fire: SGLT Inhibitors as Possible Adjunct to Closed-Loop Insulin Therapy
Pasqua, M., Tsoukas, M. A., & Haidar, A. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211035411 · Cited by 16
Hironaka, J., Okada, H., Hamaguchi, M., Sakai, K., Minamida, M., Kondo, Y., Hashimoto, Y., Kitagawa, N., Yano, M., YAMAZAKI, M., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110794 · Cited by 15
Cano, A., Llauradó, G., Albert, L., Mazarico, I., Astiarraga, B., González-Sastre, M., Martínez, L., Fernández‐Veledo, S., Simó, R., Vendrell, J. J., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072192 · Cited by 15
Pulmonary surfactant protein B carried by HDL predicts incident CVD in patients with type 1 diabetes
Shao, B., Snell‐Bergeon, J. K., Pyle, L. L., Thomas, K. E., de Boer, I. H., Kothari, V. M., Segrest, J. P., Davidson, W. S., Bornfeldt, K., & Heinecke, J. W. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100196 · Cited by 15
McEwan, P. C., Bennett, H., Bolin, K., Evans, M., & Bergenheim, K. (2018) · Diabetic Medicine · doi:10.1111/dme.13590 · Cited by 15
Healthy Living: The European Congress of Epidemiology, 2015
Bols, E. M. J., Smits, L. J. M., & Weijenberg, M. P. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0072-z · Cited by 15
Insulin resistance is more frequent in type 1 diabetes patients with long disease duration
Xie, Y., Shi, M., Ji, X., Huang, F., Li, F., Li, X., & Zhou, Z. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3640 · Cited by 14
Giménez‐Pérez, G., Viñals, C., Mata‐Cases, M., Vlacho, B., Real, J., Franch‐Nadal, J., Ortega, E., & Mauricio, D. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01917-1 · Cited by 14
Longo, M., Scappaticcio, L., Bellastella, G., Pernice, V., Cirillo, P., Maio, A., Castaldo, F., Giugliano, D., Esposito, K., & Maiorino, M. I. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s238588 · Cited by 14
Johansen, N. J., Dejgaard, T. F., Lund, A., Schlüntz, C., Larsen, E. L., Poulsen, H. E., Goetze, J. P., Møller, H. J., Vilsbøll, T., Andersen, H. U., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14078 · Cited by 14
Duin, S., Bhandarkar, S., Lehmann, S., Kemter, E., Wolf, E., Gelinsky, M., Ludwig, B., & Lode, A. (2022) · Biomedicines · doi:10.3390/biomedicines10061420 · Cited by 14
Recent developments in adjunct therapies for type 1 diabetes
Timmons, J. G., Littlejohn, L., Boyle, J. G., & Petrie, J. R. (2022) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2159806 · Cited by 14
Self-citationEpidemiología en la diabetes tipo 1: ayudando a encajar las piezas del puzle
Forga, L. (2015) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2015.02.002 · Cited by 14
Pancreatic Islet Transplantation Technologies: State of the Art of Micro- and Macro-Encapsulation
Cantarelli, E., Citro, A., & Piemonti, L. (2017) · Current Transplantation Reports · doi:10.1007/s40472-017-0154-9 · Cited by 14
Knorr, S., Juul, S., Bytoft, B., Lohse, Z., Clausen, T. D., Jensen, R. B., Damm, P., Beck‐Nielsen, H., Mathiesen, E. R., Jensen, D. M., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4575-5 · Cited by 15
Zhu, B. T. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022012 · Cited by 14
The role of proteomics in assessing beta-cell dysfunction and death in type 1 diabetes
Nakayasu, E. S., Qian, W., Evans‐Molina, C., Mirmira, R. G., Eizirik, D. L., & Metz, T. (2019) · Expert Review of Proteomics · doi:10.1080/14789450.2019.1634548 · Cited by 14
Su, C., Hsu, Y., Thangudu, S., Chen, W., Huang, Y., Yu, C., Shih, Y., Wang, C., & Lin, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-81519-7 · Cited by 13
Höhn, A., Jeyam, A., Caparrotta, T. M., McGurnaghan, S. J., O’Reilly, J. E., Blackbourn, L. A. K., McCrimmon, R. J., Leese, G., McKnight, J. A., Kennon, B., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05394-7 · Cited by 13
Self-citationWorking people with type 1 diabetes in the Finnish population
Hakkarainen, P., Sund, R., Arffman, M., Koski, S., Hänninen, V., Moilanen, L., & Räsänen, K. (2017) · BMC Public Health · doi:10.1186/s12889-017-4723-8 · Cited by 13
β cell responses to inflammation
Usmani‐Brown, S., Perdigoto, A. L., Lavoie, N., Clark, P. L., Korah, M. M., Rui, J., Betancur, G., & Herold, K. C. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.06.013 · Cited by 14
Amor, A. J., Cabrer, M., Giménez, M., Vinagre, I., Ortega, E., & Conget, I. (2016) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2016.03.008 · Cited by 12
Patient Input for Design of a Decision Support Smartphone Application for Type 1 Diabetes
Wilson, L. M., Tyler, N. S., Jacobs, P. G., Gabo, V. B., Senf, B., Reddy, R. K. K., & Castle, J. R. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819870231 · Cited by 12
Lu, C., Chang, Y., Martini, S., Chang, M., & Li, C. (2020) · Journal of Epidemiology · doi:10.2188/jea.je20200026 · Cited by 12
Interaction Between APOE Genotype and Diabetes in Longevity
Shinohara, M., Suzuki, K., Bu, G., & Sato, N. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210125 · Cited by 12
Manu, P., Rogozea, L. M., & Cernea, S. (2021) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001401 · Cited by 12
A plan to improve global type 1 diabetes epidemiology data
Beran, D., Højlund, K., Besançon, S., Loftager, M. M., Ogle, G. D., Ramaiya, K. L., Robinson, T., Svensson, J., Tuomilehto, J., Wild, S. H., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00029-3 · Cited by 12
Self-citationBody composition and metabolic syndrome in patients with type 1 diabetes
Zeng, Q., Chen, X., He, Y., Ma, Z., Wu, Y.-X., & Lin, K. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i1.81 · Cited by 12
Llauradó, G., Cano, A., Hernández, C., González-Sastre, M., Rodríguez, A.-A., Puntí, J., Berlanga, E., Albert, L., Simó, R., Vendrell, J. J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174640 · Cited by 13
Beyond type 2 diabetes: sodium glucose co‐transporter‐inhibition in type 1 diabetes
Biester, T., Kordonouri, O., & Danne, T. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13659 · Cited by 12
Nyström, T., Holzmann, M. J., & Sartipy, U. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002411 · Cited by 12
Rørth, R., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L. M., Korup, E., Signorovitch, J., Bruun, N. E., Eiskjær, H., Hassager, C., et al. (2019) · EP Europace · doi:10.1093/europace/euz114 · Cited by 11
Burden of Cardiovascular Disease in Adult Patients with Type 1 Diabetes in the US
Edelman, S. V., Zhou, F. L., Preblick, R., Verma, S., Paranjape, S., Davies, M. J., & Joish, V. N. (2020) · PharmacoEconomics - Open · doi:10.1007/s41669-019-00192-9 · Cited by 11
McGee, R., Cowell, C. T., Arnolda, G., Ting, H. P., Hibbert, P. D., Dowton, S. B., & Braithwaite, J. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001141 · Cited by 11
Karmali, R., Sipko, J., Majid, M., & Bruemmer, D. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01866-x · Cited by 11
Classification of Hypoglycemic Events in Type 1 Diabetes Using Machine Learning Algorithms
Cederblad, L., Eklund, G., Vedal, A., Hill, H., Caballero-Corbalán, J., Hellman, J., Abrahamsson, N., Johnsson, I. W., Carlsson, P., & Espes, D. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01403-7 · Cited by 11
Li, H., Tao, W., Xu, X., Chen, G., Wen-ping, M., & Jia, S. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105706 · Cited by 11
Yamagishi, S., & Matsui, T. (2015) · Rejuvenation Research · doi:10.1089/rej.2015.1738 · Cited by 11
Kamaleldeen, E. B., Mohammad, H. A., Mohamed, E. F., & Askar, A. G. (2018) · Egyptian Pediatric Association Gazette · doi:10.1016/j.epag.2018.10.003 · Cited by 11
Metadata
- Authors
- Livingstone, S. J., Levin, D., Looker, H. C., Lindsay, R. S., Wild, S. H., Joss, N., Leese, G., Leslie, P., McCrimmon, R. J., Metcalfe, W., McKnight, J. A., Morris, A. D., Pearson, D. W. M., Petrie, J. R., Philip, S., Sattar, N. A., Traynor, J. P., & Colhoun, H. M.
- Affiliations
- University of Dundee (GB)
- University of Glasgow (GB)
- University of Edinburgh (GB)
- Raigmore Hospital (GB)
- Borders General Hospital (GB)
- Scottish Renal Registry, Paisley, Scotland
- Western General Hospital (GB)
- NHS Grampian (GB)
- ORCID
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2015-01-06
- Volume
- 313
- Issue
- 1
- Pages
- 37
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC4426486
- OpenAlex
- W1965748339
- Cited by
- 621
- References
- 19
- Citations by year
- 2026: 39 · 2025: 46 · 2024: 49 · 2023: 55 · 2022: 66 · 2021: 64 · 2020: 59 · 2019: 62 · 2018: 51 · 2017: 39 · 2016: 48 · 2015: 42
- FWCI
- 52.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Funders
- Wellcome Trust (086113)
- Diabetes UK (10/0004010)
- Medical Research Council (MR/M501633/1, MR/K007017/1)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- type 1 diabetes, life expectancy, life expectancy loss, kidney disease, estimated glomerular filtration rate, ischemic heart disease, diabetic ketoacidosis, diabetic coma, sex differences, causes of death, Scotland, life expectancy at age 65
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cause of Death, Diabetes Mellitus, Type 1, Diabetic Coma, Female, Humans, Life Expectancy, Male, Middle Aged, Prospective Studies, Scotland, Sex Factors, Myocardial Ischemia, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
